FDA and CBD aren’t always seen together other than in commentary about how CBD is ignored over and over for reclassification by the agency. In early September of 2017, however, the agency put out a call for public comment via their website. They asked to hear from CBD users in a bid to actually understand how this treatment impacts the lives of so many.
What will come of this crowd sourcing? It remains to be seen but the FDA and CBD users certainly had a valuable opportunity to understand each other a little better.
FDA And CBD: Read The Comments
You can actually read the comments left electronically by heading to the Regulations.Gov site and entering the docket number: FDA-2017-N-4515. Then a new page will load and you can click on the heading, International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Ocfentanil, Carfentanil, Pregabalin, Tramadol, Cannabidiol, Ketamine, and Eleven Other Substances; Request for Comments.
There are comments from scientists and regular users alike. It’s pretty great and overwhelmingly positive.
Using CBD For Pain And Other Medical Conditions
The FDA and CBD users are coming together but what lead to this strange interaction? We’ve written several times on how research has mounted in favor of CBD treating a variety of conditions. It can ease the side effects of chemotherapy. CBD shows promise in treating epilepsy and depression. Patients with chronic pain can turn to CBD instead of more dangerous narcotic drugs to manage their daily discomfort.
The FDA And CBD A History Lesson
The DEA actually doubled down on CBD in 2016 when it classified it as a Schedule 1 drug like Heroin. The agency claimed this was purely a method of sorting applications to study cannabis concentrates, but most people on the sidelines were dubious about that. It felt like just another way to persecute cannabis users in spite of the harmless nature of the plant. As medical research shows more and more benefits for non intoxicating cannabis compounds like CBD, the FDA and DEA are blind not to take notice.
Activism is on high as users feel ignored and exploited.
The FDA CBD and WHO
The comments gathered on the FDA site will be considered in the response the US sends to the World Health Organization regarding comments will be considered in preparing a response from the United States to the World Health Organization (WHO) regarding Ocfentanil, Carfentanil, Pregabalin, Tramadol, Cannabidiol, Ketamine, and more. In turn, the WHO will take the USAs response into consideration regarding their recommendations about restricting the use and trafficking of these substances.
Stay Tuned For More On The FDA And CBD
There is surely more to hear of this story and cannabis users owe it to themselves to stay informed. The more strides forward we can make regarding the classification of cannabis the better. It’s well past time the government considered lifting cannabis’ criminal classification, especially CBD.
420 Pony will update you guys on this topic as more information becomes available. Let us know on social media if you let your voice be heard!